Platelet transfusions benefit patients with blood cancers

05/9/2013 | Medscape (free registration)

Prophylactic platelet transfusions lowered the risk of significant bleeding events in patients with blood cancers, according to a study in the New England Journal of Medicine. There was a 7% decrease in the proportion of bleeding events among patients who received platelets. "The results of our study support the need for the continued use of prophylaxis with platelet transfusion and show the benefit of such prophylaxis for reducing bleeding," researchers concluded.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA